IL1B and cancer: Thus, this study was able to obtain the expression profile of IL-18 and IL-1β interleukins in cervical tissues for the first time, and demonstrate that the reduction in IL-1β expression is linked to an increased risk between normal and cancer patients and that the reduction in IL-18 expression in HSIL patients can be used as a follow-up biomarker.